1. Home
  2. TAIT vs MEIP Comparison

TAIT vs MEIP Comparison

Compare TAIT & MEIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAIT
  • MEIP
  • Stock Information
  • Founded
  • TAIT 1989
  • MEIP 2000
  • Country
  • TAIT United States
  • MEIP United States
  • Employees
  • TAIT N/A
  • MEIP N/A
  • Industry
  • TAIT Electronic Components
  • MEIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • TAIT Technology
  • MEIP Health Care
  • Exchange
  • TAIT Nasdaq
  • MEIP Nasdaq
  • Market Cap
  • TAIT 17.2M
  • MEIP 17.9M
  • IPO Year
  • TAIT 1995
  • MEIP 2003
  • Fundamental
  • Price
  • TAIT $2.86
  • MEIP $2.75
  • Analyst Decision
  • TAIT
  • MEIP Hold
  • Analyst Count
  • TAIT 0
  • MEIP 2
  • Target Price
  • TAIT N/A
  • MEIP $7.00
  • AVG Volume (30 Days)
  • TAIT 4.8K
  • MEIP 17.7K
  • Earning Date
  • TAIT 11-12-2024
  • MEIP 11-07-2024
  • Dividend Yield
  • TAIT 6.97%
  • MEIP N/A
  • EPS Growth
  • TAIT N/A
  • MEIP N/A
  • EPS
  • TAIT 0.25
  • MEIP 2.67
  • Revenue
  • TAIT $4,719,000.00
  • MEIP $65,297,000.00
  • Revenue This Year
  • TAIT N/A
  • MEIP N/A
  • Revenue Next Year
  • TAIT N/A
  • MEIP $300.00
  • P/E Ratio
  • TAIT $11.52
  • MEIP $1.03
  • Revenue Growth
  • TAIT N/A
  • MEIP 33.76
  • 52 Week Low
  • TAIT $2.57
  • MEIP $2.61
  • 52 Week High
  • TAIT $3.65
  • MEIP $7.87
  • Technical
  • Relative Strength Index (RSI)
  • TAIT 45.09
  • MEIP 41.94
  • Support Level
  • TAIT $2.85
  • MEIP $2.63
  • Resistance Level
  • TAIT $2.91
  • MEIP $2.74
  • Average True Range (ATR)
  • TAIT 0.04
  • MEIP 0.09
  • MACD
  • TAIT -0.01
  • MEIP 0.01
  • Stochastic Oscillator
  • TAIT 16.94
  • MEIP 48.28

About TAIT Taitron Components Incorporated

Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.

About MEIP MEI Pharma Inc.

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

Share on Social Networks: